Twi Biotechnology, Inc.
Records under this name other than the patents Twi Biotechnology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 8 of 8 · Back to Twi Biotechnology, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,427,432 | Berberine formulations and uses thereof Lapsed on the fee record Ended Aug 30, 2024 · USPTO record | Lapsed on the fee record | Ended Aug 30, 2024 | USPTO record |
| US 8,183,201 | Methods of Treating AVB3 Integrin-Associated Diseases by Administering Polypeptides Selective for AVB3 Integrin Formerly held Lapsed on the fee record Ended May 22, 2024 · High confidence | Lapsed on the fee record | Ended May 22, 2024 | High confidence |
| US 9,044,436 | Compositions and Methods for the Treatment of Angiogenesis-Related Eye Diseases Formerly held Lapsed on the fee record Ended Jun 2, 2023 · Medium confidence | Lapsed on the fee record | Ended Jun 2, 2023 | Medium confidence |
| US 10,213,418 | Therapeutic uses of berberine formulations Lapsed on the fee record Ended Feb 26, 2023 · USPTO record | Lapsed on the fee record | Ended Feb 26, 2023 | USPTO record |
| US 8,865,689 | Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia Lapsed on the fee record Ended Oct 21, 2022 · USPTO record | Lapsed on the fee record | Ended Oct 21, 2022 | USPTO record |
| US 8,846,758 | Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia Lapsed on the fee record Ended Sep 30, 2022 · USPTO record | Lapsed on the fee record | Ended Sep 30, 2022 | USPTO record |
| US 8,536,152 | Methods of using diacerein as an adjunctive therapy for diabetes Lapsed on the fee record Ended Sep 17, 2021 · USPTO record | Lapsed on the fee record | Ended Sep 17, 2021 | USPTO record |
| US 7,879,906 | GABA analogs, compositions and methods for manufacturing thereof Lapsed on the fee record Ended Feb 1, 2019 · USPTO record | Lapsed on the fee record | Ended Feb 1, 2019 | USPTO record |